![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Phorm Corp | LSE:PHRM | London | Ordinary Share | SG9999009278 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMPHRM
RNS Number : 4229V
Phorm Corporation Limited
28 October 2014
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES (i) 1. Identity of the issuer Phorm Corporation Limited or the underlying issuer of existing shares to which voting rights are attached: (ii) ----------------------------- -------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): --------------------------------------------------------- An acquisition or disposal of voting rights ------------------------------------------------ ------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------ ------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------ ------- An event changing the breakdown of voting rights ------------------------------------------------ ------- Other (please Due to increase in outstanding ü specify): shares to 687,843,265 -------------- -------------------------------- ------- 3. Full name of person(s) The Capital Group Companies, subject to the notification Inc. obligation: (iii) --------------------------------- ----------------------------- 4. Full name of shareholder(s) See Schedule A (if different from 3.): (iv) --------------------------------- ----------------------------- 5. Date of the transaction 14 October 2014 and date on which the threshold is crossed or reached: (v) --------------------------------- ----------------------------- 6. Date on which issuer 15 October 2014 notified: --------------------------------- ----------------------------- 7. Threshold(s) that is/are Below 4% crossed or reached: (vi, vii) --------------------------------- ----------------------------- 8. Notified details: --------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) --------------------------------------------------------------------------------------------- Class/type Situation Resulting situation after of previous the triggering transaction shares to the triggering transaction if possible using the ISIN CODE --------------- ------------------------ -------------------------------------------------- Number Number Number Number of % of voting of of of voting rights (x) Shares Voting shares rights Rights --------------- ----------- ----------- -------- -------------------- ------------------ Direct Direct Indirect Direct Indirect (xi) (xii) --------------- ----------- ----------- -------- ------- ----------- ------- --------- Ordinary Shares SG9999009278 26,150,000 26,150,000 26,150,000 3.80% --------------- ----------- ----------- -------- ------- ----------- ------- --------- B: Qualifying Financial Instruments -------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of % of voting instrument date Conversion voting rights (xiii) Period rights that (xiv) may be acquired if the instrument is exercised/ converted. ------------------ ----------- ------------ ------------- ------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of % of voting financial price date Conversion voting rights (xix, instrument (xvii) period rights xx) (xviii) instrument refers to ------------ --------- ----------- ------------ ------------ ---------------- Nominal Delta ------------ --------- ----------- ------------ ------------ -------- ------ Total (A+B+C) ----------------------------------------------- Number of voting rights Percentage of voting rights ------------------------ --------------------- 26,150,000 3.80% ------------------------ --------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ------------------------------------------------------------ See Schedule A ------------------------------------------------------------ Proxy Voting: ------------------------------ 10. Name of the proxy holder: ------------------------------ 11. Number of voting rights proxy holder will cease to hold: ------------------------------ 12. Date on which proxy holder will cease to hold voting rights: ------------------------------ 13. Additional information: ------------------------------- -------------------- 14. Contact name: Christopher Aquino ------------------------------- -------------------- 15. Contact telephone number: (213) 615-0469 ------------------------------- --------------------
Schedule A (as notified)
As of 14 October 2014
Phorm Corporation Limited
Number Percent of Shares of Outstanding The Capital Group Companies, Inc. ("CG") holdings 26,150,000 3.80% Holdings by CG Management Companies and Funds: ------------------------------------- ----------- ---------------- -- Capital Research and Management Company 26,150,000 3.80%
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLFEFSSAFLSESS
1 Year Phorm Corp Chart |
1 Month Phorm Corp Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions